...
首页> 外文期刊>Frontiers in Immunology >The Scavenger Receptor SREC-I Cooperates with Toll-Like Receptors to Trigger Inflammatory Innate Immune Responses
【24h】

The Scavenger Receptor SREC-I Cooperates with Toll-Like Receptors to Trigger Inflammatory Innate Immune Responses

机译:清道夫受体SREC-1与类似收费的受体协同触发炎症性先天免疫反应。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Scavenger receptor expressed by endothelial cell-I (SREC-I) is a class F scavenger receptor expressed by immune cells with a significant role in CD8~(+)- and CD4~(+)-mediated T cell immunity. This receptor can also modulate the function of toll-like receptors (TLRs), which play essential roles in innate immunity. Earlier, it was found that human monocyte/macrophage THP1 cells and bone marrow-derived macrophages from mice exhibited increased responses to polyinosine–polycytidylic acid (poly I:C, PIC) and CpG (unmethylated) DNA and enhanced production of inflammatory cytokines with overexpressed SREC-I. Our data also showed that intracellular/endocytic TLR3 and TLR9 could directly interact with SREC-I in the presence of their respective ligands. We also observed that the internalized ligand along with TLR3/TLR9 colocalized in the endosome in macrophages and THP-1 cells overexpressing these receptors. In the absence of these ligands, there was no detectable colocalization between the SREC-I and endocytic TLRs. Earlier, it was shown that SREC-I stimulated double-stranded RNA/CpGDNA-mediated TLR3/TLR9 activation of the innate immune response by triggering signaling through the NF-κB, IRF3, and MAP kinase pathways leading to transcription of cytokine genes. We also established that SREC-I can associate with plasma membrane TLRs, such as TLR2 and TLR4. We demonstrated that SREC-I–TLR4 signals more efficiently from lipid microdomain in which lipopolysaccharide (LPS) can associate with SREC-I–TLR4 complex. We also proved that SREC-I is an alternate receptor for LPS capable of internalizing the complex and for endocytic TLR ligands as well. This binding activated endocytic TLR-mediated downstream cytokine production in THP1 cells and macrophages. Finally, SREC-I could also form complexes with TLR2 and induce the release of cytokines in the presence of bacterial, viral, and fungal ligands.
机译:内皮细胞I表达的清道夫受体(SREC-1)是免疫细胞表达的F类清道夫受体,在CD8〜(+)-和CD4〜(+)介导的T细胞免疫中起重要作用。该受体还可调节toll样受体(TLR)的功能,后者在先天免疫中起重要作用。早先发现,人单核细胞/巨噬细胞THP1细胞和小鼠骨髓衍生的巨噬细胞对多肌苷-聚胞苷酸(poly I:C,PIC)和CpG(未甲基化)DNA的反应增强,过表达的炎性细胞因子产生增强SREC-I。我们的数据还显示,在各自配体存在的情况下,细胞内/内吞TLR3和TLR9可以直接与SREC-1相互作用。我们还观察到内化的配体与TLR3 / TLR9一起共定位于巨噬细胞和过表达这些受体的THP-1细胞的内体中。在没有这些配体的情况下,在SREC-1和胞吞TLR之间没有可检测到的共定位。较早的研究表明,SREC-1通过触发导致细胞因子基因转录的NF-κB,IRF3和MAP激酶信号通路,刺激了先天免疫应答的双链RNA / CpGDNA介导的TLR3 / TLR9激活。我们还确定,SREC-1可以与质膜TLR(例如TLR2和TLR4)关联。我们证明,SREC-1–TLR4从脂质微结构域更有效地发出信号,其中脂多糖(LPS)可以与SREC-1–TLR4复合体缔合。我们还证明了SREC-1是LPS的一种替代受体,它能够使复合物内在化,也可以用于吞噬TLR配体。这种结合激活了THP1细胞和巨噬细胞中内吞TLR介导的下游细胞因子的产生。最后,SREC-1还可以与TLR2形成复合物,并在存在细菌,病毒和真菌配体的情况下诱导细胞因子的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号